Appraisals - ASAR & FAR

01/08/2019

Appraisal Report: emtricitabine-rilpivirine-tenofovir (Eviplera) 2374

01/08/2019

Appraisal Report: empagliflozin (Jardiance) 2746

02/08/2019

Appraisal Report: elvitegravir combination (Stribild) 1446

01/08/2019

Appraisal Report: eltrombopag (Revolade) 607

31/07/2019

Appraisal Report: rilpivirine combination (Odefsey) 3031

01/08/2019

Appraisal Report: efavirenz (Sustiva) 2666

10/02/2020

Appraisal Report: dupilumab (Dupixent) 4089

31/07/2019

Appraisal Report: dulaglutide (Trulicity) 866

31/07/2019

Appraisal Report: dolutegravir/abacavir/amivudine (Triumeq) 2365

07/08/2019

Appraisal Report: dihydroartemisinin piperaquine phosphate (Eurartesim) 1228

03/02/2020

Appraisal Report: diamorphine hydrochloride (Ayendi)2406

07/08/2019

Appraisal Report: dexmedetomidine (Dexdor) 661

01/08/2019

Appraisal Report: denosumab (Xgeva) 1870

01/08/2019

Appraisal Report: delta-9-tetrahydrocannabinol cannabidiol (Sativex) 644

06/08/2019

Appraisal Report: degarelix (Firmagon) 755

01/08/2019

Appraisal Report: defibrotide (Defitelio) 508

31/07/2019

Appraisal Report: darunavir-cobicistat (Rezolsta) 2193

25/07/2019

Appraisal Report: darunavir/cobicistat/emtricitabine/tenofovir alafenamide (Symtuza) 2418

08/08/2019

Appraisal Report: darunavir (Prezista) 1383

07/08/2019

Appraisal Report: darunavir (Prezista) 1336